Background<\/strong>: Limited anatomic resections (LARs), such as segmentectomies, performed using a fully laparoscopic approach, have gained popularity for liver malignancies. However, the oncologic efficacy of laparoscopic LARs (Lap-LARs) needs further investigation. This cohort study evaluated the oncologic outcomes of Lap-LAR for hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM). At a Japanese referral center, 112 patients underwent Lap-LAR using the Glissonean approach and indocyanine green (ICG) fluorescence navigation<\/em><\/strong>. Recurrence-free survival (RFS), overall survival (OS), time to interventional failure (TIF), and time to surgical failure (TSF) were assessed.<\/p>\n\n\n\n

Results<\/strong>: Among the 112 patients (median age, 74 years [range, 66-80 years]; 80 men [71.4 %]), Lap-LAR showed promising results. The median operative time was 348 min (range, 280-460 min), and the median blood loss was 190 mL (range, 95.5-452.0 mL). <\/p>\n\n\n\n

Lap-LAR showed favorable oncologic outcomes for HCC and CRLM<\/em><\/strong>. Its precise technique makes it a promising therapeutic option for liver malignancies. Further comparisons with conventional approaches are warranted.<\/p>\n\n\n\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/37947973\/<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Explore the promising oncologic outcomes of laparoscopic limited anatomic liver resections (Lap-LARs) for hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM), highlighting favorable results in recurrence-free survival and overall survival<\/p>\n","protected":false},"author":2,"featured_media":4773,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-4771","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\n